Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyramax efficacy and safety for falciparum malaria in African pregnant women
PACTR202011812241529Phase 3Completed
- Sponsor
- Université des Sciences, des Techniques et des Technologies de Bamako
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, open-label trial in Malaria comparing Pyramax arm, Artemether-lumefantrine arm and Dihydroartemisinin-piperaquine arm (3 arms). Primary endpoint: PCR-adjusted adequate clinical and parasitological response at Day 42. Started Jul 2020; status: completed.
02
Drugs
pyronaridineartemether + lumefantrinedihydroartemisinin + piperaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR202011812241529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202011812241529.